It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.
AbbVie forecast 2025 profit above estimates on Friday, as strong sales of its newer immunology drugs Skyrizi and Rinvoq make up for a steep decline in those of Humira, its flagship rheumatoid ...
Open Secrets (formerly the Center for Responsive Politics) is a nonpartisan nonprofit focused on providing trustworthy data about money in U.S. politics. And STAT is a media company started by Boston ...